SANTA CLARA, Calif., Sept. 28 /PRNewswire/ -- Applied Imaging Corp. (Nasdaq: AICX), announced today the
appointment of Carl W. Hull to President and Chief Operating Officer of the Company. Mr. Hull will be responsible
for running the day to day business for the Company on a worldwide basis and will continue to report to Dr. Jack
Goldstein, Chairman and Chief Executive Officer.
Mr. Hull joined Applied Imaging in 1997 and has served as Vice President of Marketing and Sales for the
Company. Prior to joining the Company he served as Vice President of Marketing and Business Development for
Ventana Medical Systems after various senior executive positions during his 14-year tenure with Abbott
Laboratories.
"With the acquisition of the Vysis cytogenetic instrument business and the launch of the Micrometastasis
Detection System (MDS(TM)) our focus must be to execute the marketing and sales plan in the field", said Jack
Goldstein, Chairman and CEO. "Carl has played a crucial role in developing and executing our growth strategy to
increase penetration into our targeted markets. We are fortunate to have such an experienced sales and marketing
executive lead us through our next stage of growth," continued Goldstein.
Applied Imaging Corporation, based in Santa Clara, Calif., develops, manufactures, and markets automated
clinical analysis systems used by laboratories for genetic characterization of cancer and prenatal disorders. The
Company markets its products worldwide and has more than 600 customer sites in over 35 countries. Applied
Imaging is a publicly traded company listed on the Nasdaq Stock Market under the Symbol AICX.
For additional information on Applied Imaging via fax, please dial
1-800-PRO-INFO, (732-544-2850 outside of the U.S.), code AICX.
SOURCE Applied Imaging Corp.
 back to top
CONTACT:
Mike Braden, Corporate Controller of Applied
Imaging, 408-562-0250; or General, Traci McCarty, or Investors,
Janet Nelson, both of The Financial Relations Board,
415-986-1591, for Applied Imaging Corp.
|
